Polar Capital Holdings PLC Neurocrine Biosciences Inc Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Polar Capital Holdings PLC holds 20,000 shares of NBIX stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,000

Previous 610,552 96.72%

Holding current value

$2.47 Million

Previous $84.1 Million 97.26%

% of portfolio

0.01%

Previous 0.51%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $67.7 Million - $90.4 Million	-590,552 Reduced 96.72%	20,000 $2.3 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $21.6 Million - $23.6 Million	-165,004 Reduced 21.28%	610,552 $84.1 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $7.86 Million - $8.66 Million	-60,277 Reduced 7.21%	775,556 $107 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $54.2 Million - $67.8 Million	510,833 Added 157.18%	835,833 $110 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $4.7 Million - $5.86 Million	-50,000 Reduced 13.33%	325,000 $36.6 Million
Q2 2023 Dec 13, 2023	BUY	$89.53 - $104.87 $4.48 Million - $5.24 Million	50,000 Added 15.38%	375,000 $35.4 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $33.6 Million - $39.3 Million	375,000 New	375,000 $35.4 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $56.2 Million - $65.8 Million	-610,341 Reduced 77.82%	173,946 $18.5 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $1.89 Million - $2.5 Million	25,000 Added 3.29%	784,287 $76.5 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $52.5 Million - $68.7 Million	725,000 Added 2114.5%	759,287 $71.2 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $356,194 - $475,015	4,472 Added 15.0%	34,287 $2.92 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $11.6 Million - $13.3 Million	-134,158 Reduced 81.82%	29,815 $2.86 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $3.14 Million - $3.6 Million	35,156 Added 27.29%	163,973 $16 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $525,420 - $716,400	6,000 Added 4.89%	128,817 $12.5 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $10.7 Million - $13.3 Million	122,817 New	122,817 $11.8 Million

Others Institutions Holding NBIX

# of Institutions

624

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Neurocrine Biosciences Inc Transaction History